Gen Re and PAI Health Take Strategic Partnership to Next...

Decades of evidence have proven cardiorespiratory fitness to be a leading predictor of longevity and future health. Yet it is one that has been largely overlooked within insurance customer health profiles. With the signing of the exclusive agreement between leading global reinsurer, Gen"...

Makita Pink creates awareness on breast cancer

Every year in October, the colour pink is prominently showcased by thousands of organizations everywhere. October has been designated as the Pink Month in a global effort to raise awareness on Breast Cancer.

The"...

KSRelief sets up mobile clinics to treat Yemenis

SANAA: Saudi Arabia is leaving no stone unturned to provide humanitarian aid throughout Yemen without any discrimination.

In this regard, the Kingdom has launched several projects through the King Salman Humanitarian"...

GN CORPORATION: Vision Restored with Corneal Cell Transplant...

A novel cell transplantation method to treat corneal endothelial diseases such as bullous keratopathy using a nano-composite gel sheet developed by Japanese scientists was granted Indian patent to GN Corporation (GNC), Japan. This method was earlier granted a Japanese patent, in which one"...

Takeda Presents Long-Term Data in ALK+ NSCLC Showing ALUNBRIG®...

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced updated data from the Phase 3 ALTA-1L trial, which evaluated ALUNBRIG versus crizotinib in adults with advanced anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) who had not received a prior ALK inhibitor. Results show after more than two years of follow-up, ALUNBRIG reduced the risk of disease progression or death by 76% (hazard ratio [HR] = 0.24, 95% CI: 0.12–0.45) as assessed by investigators in newly diagnosed patients whose disease had spread to the brain at time of enrollment. ALUNBRIG also demonstrated a 57% (HR = 0.43, 95% CI:......

KSrelief Continues its Strategic Support for Medical Sector...

King Salman Humanitarian Aid and Relief Center (KSrelief), in coordination with Yemeni Higher Committee for Relief, represented by the Ministry of Public Health and Population of Yemen, has initiated a strategic plan to support the public and private health sectors.

This"...

Takeda Presents 18-Month Data from Pivotal Phase 3 Trial...

Takeda Pharmaceutical Company Limited (TSE:4502 / NYSE:TAK) (“Takeda”) today announced that updated results from the ongoing pivotal Phase 3 Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial of its dengue vaccine candidate (TAK-003) were presented at the American Society of Tropical Medicine and Hygiene (ASTMH) 68th Annual Meeting. The data presented include an update on overall vaccine efficacy (VE) and a formal assessment of secondary efficacy endpoints by serotype, baseline serostatus and disease severity (18 months after the second dose, which was administered three months after the first dose). The TIDES trial......

Awareness campaign to get rid of epidemics started in Hodeidah...

HODEIDAH, Nov. 24 (Saba) - The local authority of Hodeidah province in cooperation with the health office launched on Saturday an awareness campaign to get rid of diseases and epidemic.

The campaign aimed at to"...

Ferring and Blackstone Life Sciences Invest Over $570 Million...

Ferring Pharmaceuticals and Blackstone Life Sciences today announced the joint investment of over $570 million USD in nadofaragene firadenovec (rAd-IFN/Syn3), an investigational novel gene therapy in late stage development for patients with high-grade, Bacillus Calmette-Guérin (BCG)"...

Health Minister calls UN to help to save children from diseases...

SANAA, Nov. 23 (Saba) - Minister of Health Taha Al-Mutawakel on Saturday called for the United Nations to help Yemen in entry essential medicines for save Yemeni children from diseases and epidemic.

The move came"...